Advertisement
Cannabidiol can reduce seizure frequency in patients with Dravet Syndrome

Cannabidiol Promising for Seizures in Dravet Syndrome

0
Greater reduction in convulsive-seizure frequency, higher rates of adverse events than placebo
A normal meal tolerance test -- a simplified version of the mixed meal tolerance test -- is valuable as an insulin secretion test in patients with type 2 diabetes

Normal Meal Tolerance Test Is Practical, Reliable in T2DM

0
But glucagon stimulation test should be used instead for patients in hyperglycemic state
Patients taking opioids before total knee arthroplasty may have greater pain after the procedure

Opioid Use Before TKA May Lead to Worse Pain After Surgery

0
Researchers suggest limiting opioid prescriptions might optimize benefits of TKA
Bronchial thermoplasty

ATS: Bronchial Thermoplasty Has Lasting Benefits for Asthma

0
Reduction in severe exacerbations, hospitalizations, ER visits in first and second year of follow-up
Prescription databases can help combat drug abuse when doctors are required by law to check them before writing opioid prescriptions

Doctors Urged to Check Patient Drug History Before Opioid Rx

0
Opioid abuse down when physicians are legally obligated to check patient's drug history
Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat any cancer that has a certain genetic biomarker

FDA Approves Keytruda for All Cancers With Genetic Biomarker

0
First medication sanctioned for any cancer, regardless of origin
For patients undergoing percutaneous coronary intervention with drug-eluting stents

Risk Up for Triple Tx Versus DAPT in DES Implantation With A-Fib

0
Findings for patients with atrial fibrillation who underwent PCI with drug-eluting stents
Polyneuropathy is associated with increased likelihood of receiving long-term opioids

Patients With Polyneuropathy More Often Receive Opioids

0
No functional status markers improve with long-term opioid use, but adverse outcomes more common
Benralizumab is associated with a significant reduction in glucocorticoid doses among adults with severe asthma

ATS: Benralizumab Reduces Glucocorticoid Doses in Asthma

0
Significant 75 percent reduction in median final oral glucocorticoid doses from baseline
The benefit of pravastatin for primary prevention in older adults with moderate hyperlipidemia and hypertension is questionable

Statin Therapy Found to Be of Little Benefit in Older Adults

0
No primary cardiovascular prevention benefit seen for statins in those 65 and older